HES1 and colorectal carcinoma: It was shown that 5-FU, Oxaliplatin and Irinotecan-induced chemoresistance in CRC cells was promoted by Notch transcription factors, such as HES1, and abrogated using Notch inhibitory therapy using Gamma -Secretase Inhibitors (GSI) (Meng et al., 2007).